Trends and disparities in age, sex, ethnoracial background, and urbanization status in adult mortality due to thoracic aortic aneurysm: a retrospective nationwide study in the United States Authors: Aman Goyal, Humza Saeed, Urooj Shamim, Momina R. Siddiqui, Abdullah, Muhammad K. Arshad, Hritvik Jain, Mohamed Daoud, Rozi Khan, Kamna Bansal Published: 2024 ABSTRACT Introduction:Thoracic aortic aneurysms (TAA) are a significant health concern, with the true prevalence likely underestimated due to undiagnosed cases. Outcomes in TAA are influenced by factors like age, sex, and comorbidities such as hypertension. This study examines mortality trends and disparities associated with TAA in US adults.Methodology:This study analyzed death certificates from 1999 to 2020 using the CDC WONDER Database to identify TAA-related deaths in individuals aged 25 and older using ICD-10 codes I71.1 and I71.2. Age-adjusted mortality rates (AAMRs) per 1 000 000 and annual percent changes (APCs) were calculated and stratified by year, sex, age group, race/ethnicity, region, and urbanization status.Results:Between 1999 and 2020, 47 136 TAA-related deaths were reported among US adults. The AAMR decreased from 16.2 to 8.2 per 1 000 000, with a significant decline from 1999 to 2013 (APC: −5.00; 95% CI: −5.54 to −4.54; P<0.001). Older adults had the highest AAMRs at 44.6 per 1 000 000. Men had higher AAMRs than women (11.2 vs. 9). AAMRs were highest among non-Hispanic (NH) Black (11), followed by NH White (10.3), NH Asian or Pacific Islander (9.5), NH American Indian or Alaska Native (7.8), and Hispanic (5.2) populations. Nonmetropolitan areas had higher AAMRs than metropolitan areas (11 vs. 9.8).Conclusions:The analysis showed a significant decline in TAA mortality since 1999, with recent stabilization. However, disparities persist, with higher AAMRs among men, older adults, NH Black adults, and nonmetropolitan residents, highlighting the need for targeted and equitable interventions. Introduction Highlights Significant decline in mortality: Thoracic aortic aneurysm (TAA) mortality rates in the U.S. significantly decreased from 1999 to 2013, with age-adjusted mortality rates (AAMRs) dropping from 16.2 to 8.2 per million. Significant decline in mortality: Thoracic aortic aneurysm (TAA) mortality rates in the U.S. significantly decreased from 1999 to 2013, with age-adjusted mortality rates (AAMRs) dropping from 16.2 to 8.2 per million. Persistent demographic disparities: Despite overall declines, disparities persist, with higher mortality rates observed among men, older adults, non-Hispanic Black individuals, and residents of nonmetropolitan areas. Persistent demographic disparities: Despite overall declines, disparities persist, with higher mortality rates observed among men, older adults, non-Hispanic Black individuals, and residents of nonmetropolitan areas. Need for targeted interventions: The study highlights the ongoing need for targeted and equitable interventions to address the higher mortality rates among vulnerable populations, such as men, older adults, and non-Hispanic Black individuals. Need for targeted interventions: The study highlights the ongoing need for targeted and equitable interventions to address the higher mortality rates among vulnerable populations, such as men, older adults, and non-Hispanic Black individuals. Thoracic aortic aneurysm (TAA) is a serious vascular disorder characterized by the abnormal dilation of the thoracic portion of the aorta. This condition can lead to life-threatening complications, including aortic rupture and dissection, which are associated with high mortality rates despite advances in medical and surgical interventions1. Although TAA is less common than abdominal aortic aneurysms, it carries a significant risk of morbidity and mortality2. The incidence and prevalence of TAA have shown an upward trend in the United States (US), partly due to advancements in diagnostic imaging techniques and an aging population3. Current estimates suggest a prevalence rate of six to ten per 100 000 individuals, but this may be underestimated due to the often asymptomatic nature of the condition, leading to undiagnosed cases2. The etiology of TAA is multifactorial, with key risk factors including advanced age, male sex, hypertension, smoking, and genetic predispositions4. Additionally, older studies have demonstrated demographic disparities in the outcomes of ruptured TAA, with mortality rates varying significantly across different demographic groups5. Despite the growing body of research on TAA, there remains a lack of comprehensive data on the long-term trends in TAA-related mortality across different demographic groups. Understanding these trends is crucial for developing targeted interventions and improving outcomes for at-risk populations. Therefore, this study aims to analyze the temporal trends, sex differences, and ethnoracial disparities in TAA-related mortality among adults in the US from 1999 to 2020. The study focuses on adults aged 25 and older because TAA is rare in younger individuals, with the number of patients being too low to detect statistical significance. The year 2020 was chosen as the end of the study period to utilize the most recent and complete data available from the CDC WONDER database. Methodology Study setting and population The mortality data for this study was obtained from the Centers for Disease Control and Prevention’s (CDC) Wide-Ranging Online Data for Epidemiologic Research (WONDER) database6. We analyzed mortality rates due to TAA in adults aged 25 and older from 1999 to 2020 using this comprehensive database. Specifically, we focused on the Multiple Cause-of-Death Public Use Record database to identify cases where TAA was listed as either the underlying or the contributing cause of death on death certificates across the US7. This database and method have been previously utilized in various papers analyzing mortality data8–10. The International Statistical Classification of Diseases and Related Health Problems (ICD-10), 10th Revision codes I71.1 and I71.2 were used to identify cases of both ruptured and without mention of rupture TAA11. Institutional review board approval was not required for this study, as we used a government-provided, de-identified, publicly available dataset. This cross-sectional study was conducted following the strengthening the reporting of cohort studies in surgery (STROCSS, Supplemental Digital Content 1, http://links.lww.com/JS9/D537) guidelines12. Data abstraction The data were categorized according to various demographic variables, including population size, age distribution, sex composition, racial/ethnic background, geographic location, urbanization level, and place of death. The places of death included medical facilities (consisting of inpatient settings, outpatient facilities, emergency rooms, cases of death upon arrival), decedents’ homes, hospices, nursing homes/long-term care facilities, and cases where the location was unspecified. Racial and ethnic categories consisted of Hispanic or Latino, non-Hispanic (NH) White, NH Black, NH American Indian/Alaska Native, and NH Asian/Pacific Islander. These classifications align with those previously used in analyses from the CDC WONDER database and are based on data reported on death certificates in compliance with the US Office of Budget and Management Guidelines7. The patients were also segmented into 10-year intervals based on whether they were young adults (25–44 years), middle-aged adults (45–64 years), or older adults (65–85+ years). This age distribution is chosen in line with previous studies using the CDC WONDER data10. We used the Urban-Rural Classification Scheme of the National Center for Health Statistics to categorize our study population geographically, with urban areas defined as having populations of 50 000 or more and rural areas having fewer than 50 000 residents. Furthermore, we divided the US into four regions, as per the US Census Bureau’s classification: Northeast, Midwest, South, and West13. Statistical analysis Age-adjusted mortality rates (AAMR) for TAA per 1 000 000 people were calculated to account for differences in the age distribution of the population over time, ensuring that the mortality rates are comparable across years. AAMR was standardized to the 2000 US population using direct age standardization, a widely accepted method that allows for the comparison of mortality rates while adjusting for age differences in the population14. To analyze trends in AAMR of TAA-related mortality, the Joinpoint regression program (Version 5.0.2, National Cancer Institute) was used15. Temporal trends in AAMR were assessed by fitting log-linear regression models. Joinpoint regression was applied to identify inflection points in the temporal trends of AAMR for TAA from 1999 to 2020, based on published methodological guidelines. For datasets with 17 to 21 time-points, the guidelines recommend identifying a maximum of three inflection points over the study period. Since this study includes 22 years, the Joinpoint regression software was set to identify up to four joinpoints where significant temporal variations in the trend existed. However, fewer than the maximum allowed number of inflection points could be identified if the magnitude of variation between trends was greatest with fewer inflection points. Thus, the analysis allowed for identifying between 0 and 4 joinpoints. The Grid Search method (0,2), combined with a permutation test and parametric method, was used to estimate the annual percent change (APC) and corresponding 95% CIs. APC describes the rate of change in AAMR over time, providing a measure of whether mortality rates are increasing or decreasing each year. A positive APC indicates an increase, and a negative APC reflects a decrease in mortality rates. APC values were considered significant if their CI did not include zero, based on 2-tailed t-tests. Statistical significance was set at P≤0.05. Results Between 1999 and 2020, 47 136 deaths occurred among US adults where TAA was an underlying or contributing cause (Supplemental Table 1, Supplemental Digital Content 2, http://links.lww.com/JS9/D538). The place of death was recorded for 45 604 cases: 63% in medical facilities, 22.7% in decedents’ homes, 9.2% in nursing homes or long-term care facilities, and 1.8% in hospices (Supplemental Table 2, Supplemental Digital Content 2, http://links.lww.com/JS9/D538). Demographic trends in mortality The overall AAMR for adults due to TAA was 16.2 per 1 000 000 individuals in 1999, which declined to 8.2 in 2020. From 1999 to 2013, the AAMR showed a significant decrease (APC: −5.00; 95% CI: −5.54 to −4.54; P<0.001), followed by a period of stability until 2020 (APC: 0.47; 95% CI: −1.02 to 3.06; P=0.476) (Fig. 1, Supplemental Tables 3 and 4, Supplemental Digital Content 2, http://links.lww.com/JS9/D538). (A) Overall and sex-stratified Thoracic Aortic Aneurysm-related Age-Adjusted Mortality Rates (AAMRs) per 1 000 000 adults in the United States, 1999 to 2020. (B) Graphical representation of Joinpoint analysis with Annual Percentage Change (APC) in overall and sex-stratified AAMRs during the same period. * indicates that the APC is significantly different from zero at α=0.05. Gender stratification During the study period, men had higher AAMRs than women (11.2 vs. 9.0). Among men, the AAMR significantly decreased from 1999 to 2012 (APC: −5.84; 95% CI: −6.86 to −5.10; P<0.001), followed by a period of stability until 2020 (APC: 1.58; 95% CI: −0.12 to 4.54; P=0.063). In women, the AAMR also showed a significant decrease from 1999 to 2014 (APC: −4.58; 95% CI: −6.58 to −4.00; P=0.009), followed by a stable period until 2020 (APC: −0.71; 95% CI: −3.23 to 7.04; P=0.717) (Fig. 1, Supplemental Tables 3 and 4, Supplemental Digital Content 2, http://links.lww.com/JS9/D538). Stratification by age groups When stratified by age groups, older adults had the highest AAMRs (44.6), followed by middle-aged adults (3.0) and young adults (0.6). Among young adults, AAMRs remained relatively stable from 1999 to 2020 (APC: −0.28; 95% CI: −1.26 to 0.71; P=0.551). Middle-aged adults experienced a significant decrease in AAMRs from 1999 to 2008 (APC: −5.39; 95% CI: −8.11 to −2.82; P=0.027), followed by a period of stability from 2008 to 2018. However, from 2018 to 2020, AAMRs among middle-aged adults showed a steep upward trend (APC: 7.94; 95% CI: 0.96–12.66; P=0.004). For older adults, AAMRs significantly decreased between 1999 and 2014 (APC: −5.10; 95% CI: −5.85 to −4.55; P<0.001), followed by a stable period until 2020 (APC: 0.80; 95% CI: −1.45 to 6.70; P=0.390) (Fig. 2, Supplemental Tables 3 and 5, Supplemental Digital Content 2, http://links.lww.com/JS9/D538). Thoracic Aortic Aneurysm-related Age-Adjusted Mortality Rates (AAMRs) per 1 000 000 in the United States, 1999 to 2020. (A) AAMRs for young and middle-aged adults. (B) AAMRs for older adults. (C) Graphical representation of Joinpoint analysis with Annual Percentage Change (APC) for AAMRs in young and middle-aged adults. (D) Graphical representation of Joinpoint analysis with APC for AAMRs in older adults. * indicates that the APC is significantly different from zero at α=0.05. Ethnoracial stratification When stratified by race and ethnicity, AAMRs were highest among NH Black adults11, followed by NH White (10.3), NH Asian or Pacific Islander (9.5), NH American Indian or Alaska Native (7.8), and Hispanic (5.2) adults. Trend analysis was not possible for NH American Indians or Alaska Natives due to unreliable mortality data. Among NH Asians or Pacific Islanders, the AAMR significantly decreased from 1999 to 2011 (APC: −6.38; 95% CI: −11.64 to −4.72; P=0.004) and then remained stable until 2020. Similar trends were observed among NH Black adults, with a significant decline in AAMR from 1999 to 2015 (APC: −4.97; 95% CI: −9.22 to −3.98; P=0.014), followed by stability until 2020. NH White individuals also showed a significant decline from 1999 to 2013 (APC: −4.90; 95% CI: −5.51 to −4.44; P<0.001), followed by a stable period until 2020. Among Hispanics, the AAMR decreased significantly from 1999 to 2020 (APC: −3.17; 95% CI: −3.99 to −2.20; P<0.001) (Fig. 2, Supplemental Tables 3 and 6, Supplemental Digital Content 2, http://links.lww.com/JS9/D538). State-wise distribution AAMR values varied significantly by state, ranging from 5.9 in Utah to 14.9 in Vermont. States in the top 90th percentile (Oregon, North Dakota, Wyoming, West Virginia, Hawaii, Minnesota, Vermont) had AAMRs about twice than those in the bottom 10th percentile (Arizona, Louisiana, Georgia, Texas, New Mexico, Utah) (Fig. 3, Supplemental Table 7, Supplemental Digital Content 2, http://links.lww.com/JS9/D538). (A) Thoracic Aortic Aneurysm-related Age-Adjusted Mortality Rates (AAMRs) per 1 000 000, stratified by race and ethnicity in adults in the United States, 1999 to 2020. (B) Graphical representation of Joinpoint analysis with Annual Percentage Change (APC) for AAMRs stratified by race and ethnicity during the same period. * indicates that the APC is significantly different from zero at α=0.05. Census region The AAMRs varied slightly among the census regions, with the highest in the Midwestern region (11.1), followed by the Northeastern (10.2), Western10, and Southern (9.2) regions. In the Northeastern region, the AAMR significantly decreased from 1999 to 2016 (APC: −4.71; 95% CI: −5.76 to −4.16; P<0.001) and then stabilized until 2020. Similarly, in the Midwestern region, the AAMR significantly decreased from 1999 to 2014 (APC: −4.78; 95% CI: −5.62 to −4.19; P<0.001) before stabilizing until 2020. In the Southern region, the AAMR significantly decreased from 1999 to 2013 (APC: −5.36; 95% CI: −6.03 to −4.84; P<0.001) and then remained stable until 2020. The Western region observed a sharp decline from 1999 to 2001 (APC: −10.45; 95% CI: −13.71 to −4.49; P<0.001), followed by stability until 2020 (Figs. 4, 5, Supplemental Tables 3 and 8, Supplemental Digital Content 2, http://links.lww.com/JS9/D538). (A) and (B) Thoracic Aortic Aneurysm-related Age-Adjusted Mortality Rates per 1 000 000, Stratified by State in Adults in the United States, 1999 to 2020. (A) Thoracic Aortic Aneurysm-related Age-Adjusted Mortality Rates (AAMRs) per 1 000 000, stratified by Census regions in adults in the United States, 1999 to 2020. (B) Graphical representation of Joinpoint analysis with Annual Percentage Change (APC) for AAMRs stratified by Census regions during the same period. * indicates that the APC is significantly different from zero at α=0.05. Urbanization Throughout the study period, AAMR values were higher in nonmetropolitan areas compared to metropolitan areas (11 vs. 9.8). In nonmetropolitan areas, the AAMR significantly decreased from 1999 to 2014 (APC: −4.15; 95% CI: −6.58 to −3.49; P=0.007) and then stabilized from 2014 to 2020 (APC: 0.69; 95% CI: −2.48 to 10.45; P=0.629). Similarly, in metropolitan areas, AAMR values significantly decreased from 1999 to 2013 (APC: −5.16; 95% CI: −5.91 to −4.63; P<0.001), followed by a period of stability until 2020 (APC: 0.55; 95% CI: −1.24 to 4.18; P=0.465) (Fig. 6, Supplemental Tables 3 and 9, Supplemental Digital Content 2, http://links.lww.com/JS9/D538). (A) Thoracic Aortic Aneurysm-related Age-Adjusted Mortality Rates (AAMRs) per 1 000 000 in adults in metropolitan and nonmetropolitan areas in the United States, 1999 to 2020. (B) Graphical representation of Joinpoint analysis with Annual Percentage Change (APC) for AAMRs in metropolitan and nonmetropolitan areas during the same period. * indicates that the APC is significantly different from zero at α=0.05. Discussion Thoracic aortic aneurysm (TAA) represents a considerable health burden. The true incidence and prevalence of TAA are likely higher than currently recognized due to the disease’s often clinically silent nature, making it even more challenging to study3. Our study observed a notable reduction in AAMRs due to TAA among adults, decreasing from 16.2/1 000 000 individuals in 1999 to 8.2/1 000 000 in 2020, specifically witnessing a sharp decline from 1999 to 2013, followed by a period of stability until 2020. One of the main contributors to this trend is the rapid evolution of imaging technology. The widespread adoption of advanced diagnostic techniques, such as computed tomography (CT) and MRI, improved the ability to detect TAAs earlier and with greater precision, leading to timely interventions and better patient outcomes16. Furthermore, the introduction and refinement of surgical and endovascular techniques have played a significant role in reducing TAA-related mortality. During this period, the adoption of minimally invasive approaches, such as endovascular treatments, became more common. These treatments have been shown to reduce perioperative morbidity and mortality compared to open surgical repair, particularly in high-risk patients or those with complex aneurysms17. Another critical factor is the implementation of more comprehensive guidelines and protocols for the management of aortic aneurysms. The availability of risk stratification tools and improved patient selection criteria helped identify patients who would benefit most from surgery, optimizing treatment strategies, and minimizing complications18. The development and increased use of antihypertensive and lipid-lowering medications, such as beta-blockers and statins, also contributed to the decline. These medications help manage risk factors that predispose individuals to aortic disease, reducing the incidence and progression of TAAs. Public health initiatives and greater awareness among healthcare professionals regarding the importance of early detection and intervention of aortic aneurysms further supported these improvements19. Screening recommendations for high-risk populations, such as those with a family history of aortic disease or genetic conditions like Marfan syndrome, became more standardized, facilitating early diagnosis and management20. Therefore, while the overall decline in TAA-related mortality can be attributed to several factors, the significant reduction from 1999 to 2013 likely reflects a period of intense medical innovation, advancements in surgical techniques, and improvements in risk management and early detection. Gender disparities were noted in TAA-related AAMRs, in which men consistently exhibited higher AAMRs than women. This finding is consistent with previous research suggesting that men are at a greater risk of developing TAA, likely due to a combination of biological factors such as differences in aortic wall structure, as well as a higher prevalence of risk factors like hypertension and smoking among men21,22. Initially, AAMRs were reduced significantly in both sexes due to substantial healthcare advancements as described above23. However, the stabilization of mortality rates in both sexes in the later years indicates a potential plateau; this warrants a further need for investigation into additional strategies that could further reduce TAA-related mortality, particularly among women24. Even though men are reported to have worse AAMRs than women, there is sufficient data present in the literature that highlights the fact that women are known to present with TAA at a later stage and with larger aneurysms when compared with men. Aneurysms in women tend to grow more slowly and remain asymptomatic for a longer period of time. This results in women experiencing more complications, such as ruptures, which could occur before diagnosis or treatment. Some studies have also shown that women are comparatively less likely to undergo timely surgical intervention and may experience worse postoperative outcomes than men24,25. The stratification of mortality rates by age group reveals that older adults (65 years and above) have the highest AAMRs, which is consistent with the understanding that age is a significant risk factor for TAA26. The steep decline in AAMRs among older adults between 1999 and 2014 is a positive indicator of the impact of improved healthcare practices targeting this vulnerable population27. The observed upward trend in age-adjusted mortality rates (AAMRs) among middle-aged adults (45–64 years) between 2018 and 2020 warrants closer examination, as it may signal emerging risk factors or underlying changes in healthcare delivery5. One potential contributor to the upward trend in AAMRs among middle-aged adults is the rising prevalence of uncontrolled hypertension and diabetes, both of which are significant risk factors for TAA28,29. Noncompliance with antihypertensive and glycemic control therapies, due to factors like medication costs or inconsistent follow-up care, may contribute to a higher incidence of aortic disease or rapid aneurysm expansion and even rupture, thereby increasing the mortality risk30,31. Additionally, the increased prevalence of lifestyle-related factors, such as obesity and smoking, further exacerbates TAA risk32,33. Obesity accelerates aortic wall degeneration, while smoking impairs postoperative outcomes and promotes aortic disease34,35. Healthcare access issues, including transitions in coverage and delayed care, may also explain the rise in mortality36,37. Furthermore, the onset of the COVID-19 pandemic disrupted routine care and exacerbated psychosocial stress and unhealthy behaviors, contributing to worsened outcomes during this period38,39. Racial and ethnic disparities in TAA-related mortality are another noteworthy finding of our study. NH Black individuals had the highest AAMRs. This was followed by NH Whites, NH Asians, or Pacific Islanders, NH American Indians or Alaska Natives, and Hispanics. Similar findings were depicted in other studies reflecting persistently higher mortality rates among NH Blacks adults, which may be attributed to differences in access to care, socioeconomic factors, and the prevalence of risk factors such as hypertension, smoking, and diabetes4,5,40. The significant decline in AAMRs across all racial and ethnic groups until the early 2010s is benefiting, yet subsequent stabilization may indicate that these groups may not be equally benefiting from existing healthcare advancements. Hypertension and smoking, which are disproportionately higher in certain racial and ethnic groups, such as NH Black male adults, are particularly important contributors to these disparities, as both are well-established risk factors for TAA development and progression4,41–43. Addressing these risk factors through targeted interventions is essential to reducing the gap in outcomes. This emphasizes the need for targeted public health interventions and policies aimed at improving access to preventive care and treatment, particularly in underserved communities. Policy recommendations include expanding access to affordable healthcare, implementing community-based health education programs focused on risk factor management (e.g. hypertension control and smoking cessation), and enhancing screening efforts in high-risk racial and ethnic populations. Additionally, promoting diversity within the healthcare workforce and ensuring culturally sensitive care can help address these disparities and achieve more equitable health outcomes. Our analysis reveals significant geographic disparities, with states in the Midwest and Northeast regions showing higher AAMRs compared to the Southern and Western regions. Additionally, nonmetropolitan areas had higher AAMRs than metropolitan areas, reflecting the challenges faced by rural populations in accessing timely and advanced healthcare44. The stabilization of mortality rates in both metropolitan and nonmetropolitan areas after 2014 suggests that while initial improvements were made, further efforts are needed to close the gap between rural and urban healthcare outcomes. In recent years, the introduction and widespread use of minimally invasive procedures, such as thoracic endovascular aortic repair (TEVAR) and endovascular aneurysm repair (EVAR), have significantly transformed the management of TAA45,46. Studies have consistently shown that patients undergoing TEVAR or EVAR experience improved postoperative outcomes, shorter recovery times, and fewer complications compared to those undergoing traditional open surgical repair. Moreover, these procedures have expanded the eligibility criteria for TAA repair, providing an option for older and high-risk patients who were previously deemed unsuitable candidates for open surgery due to comorbidities or advanced age45–47. Despite the clinical benefits of these minimally invasive procedures, their utilization remains inconsistent across different healthcare settings. Disparities in the adoption of TEVAR and EVAR are evident, particularly between metropolitan and nonmetropolitan areas, where limited access to specialized centers, financial constraints, and differences in healthcare infrastructure impede the widespread adoption of these advanced techniques48. This variability suggests that not all patients are benefiting equally from advancements in TAA management, exacerbating disparities in outcomes. Minority populations and individuals in rural or low-resource areas are disproportionately affected due to barriers like lower healthcare literacy, limited insurance, and lack of proximity to high-volume surgical centers37,49. Promoting equitable access to minimally invasive procedures like TEVAR and EVAR is crucial. This can be achieved by raising awareness among healthcare providers and patients, expanding surgeon training in endovascular techniques, and implementing policies to subsidize or reduce costs in underserved areas. Building capacity for endovascular procedures in nonmetropolitan hospitals and community health centers is also essential to bridging the geographic and socioeconomic gap in TAA care50. Future research should focus on optimizing the long-term outcomes of TEVAR and EVAR, including durability, risk factors for reinterventions, and identifying the populations most likely to benefit. Additionally, strategies to enhance referral pathways and assess the cost-effectiveness of expanding these services in under-resourced settings should be explored51. Broader and more equitable adoption of these techniques is essential to reducing TAA-related mortality and addressing the persistent disparities in cardiovascular outcomes across different races, ethnicities, and regions. Limitations Despite the robustness of the data and analysis, our study has several limitations that may affect the interpretation of the results. First, reliance on death certificate data may lead to misclassification or incorrect reporting of TAA as the cause of death, potentially resulting in an overestimation or underestimation of TAA-related mortality, thus compromising the accuracy of observed trends and disparities. Second, the absence of individual-level data on comorbidities, socioeconomic and lifestyle factors, and healthcare access limits our ability to fully explore the drivers of these disparities, as such factors likely vary across demographic groups and may significantly impact both TAA development and outcomes. Third, the CDC WONDER database does not offer options for matched or stratified analysis, introducing the risk of confounding bias that must be considered. Fourth, the lack of information on diagnostic tools and management strategies, such as imaging modalities or frequency of screening, hinders our ability to assess how differences in diagnosis and treatment impact mortality trends; undiagnosed, asymptomatic cases may go unreported, and variations in diagnostic capabilities across healthcare settings—particularly between rural and urban areas—may skew the data, affecting reported mortality rates and leading to an incomplete understanding of TAA mortality. Fifth, we were unable to conduct additional analyses, such as goodness-of-fit tests and residual analysis, due to the limitation of the CDC WONDER database in providing individual patient-level data. Lastly, our reliance on aggregate data restricts the exploration of causal relationships between observed trends and healthcare interventions or policies, making it challenging to determine the impact of specific public health measures or treatments on identified mortality trends. Future studies should aim to address these limitations by incorporating prospective individual-level data and detailed clinical information to better understand the factors influencing TAA mortality and disparities. Conclusion TAA-related mortality in the US has declined from 1999 to 2020, but disparities persist. Men, older adults, NH Black individuals, and nonmetropolitan residents still face higher mortality rates. Targeted interventions and timely public health measures are needed to enhance early detection, treatment, and prevention in these high-risk populations, aiming to reduce disparities and improve health outcomes. Ethical approval No ethical approval was required for this study design, as all data were obtained from publicly available sources. Consent Informed consent was not required as we utilized data from a de-identified government-provided public use dataset. Source of funding Not applicable. Author contribution A.G., H.S.: conceptualization, formal analysis, methodology, and writing – original draft; U.S.: methodology and writing – original draft; M.R.S.: methodology, software, and formal analysis; A.: data curation and writing – original draft; M.K.A.: formal analysis and data curation; H.J.: formal analysis, methodology, and writing – review and editing; M.D.: methodology and writing – original draft; R.K.: data curation, supervision, and writing –review and editing; K.B.: conceptualization, data curation, supervision, and writing – review and editing. Conflicts of interest disclosure The authors declare no conflicts of interest. Research registration unique identifying number (UIN) Name of the registry: not applicable.Unique identifying number or registration ID: not applicable.Hyperlink to your specific registration (must be publicly accessible and will be checked): not applicable. Name of the registry: not applicable. Name of the registry: not applicable. Unique identifying number or registration ID: not applicable. Unique identifying number or registration ID: not applicable. Hyperlink to your specific registration (must be publicly accessible and will be checked): not applicable. Hyperlink to your specific registration (must be publicly accessible and will be checked): not applicable. Guarantor Aman Goyal, MBBS. Data availability statement The data supporting the findings of this study are openly available in CDC Wonder at [https://wonder.cdc.gov/]. Provenance and peer review Not commissioned, externally peer-reviewed. Supplementary Material SUPPLEMENTARY MATERIAL